US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy.
| Autor: | Duke, Elizabeth S., Bradford, Diana, Sinha, Arup K., Mishra-Kalyani, Pallavi S., Lerro, Catherine C., Rivera, Donna, Wearne, Emily, Miller, Claudia P., Leighton, John, Sabit, Hairat, Zhao, Hong, Lane, Ashley, Scepura, Barbara, Pazdur, Richard, Singh, Harpreet, Kluetz, Paul G., Donoghue, Martha, Drezner, Nicole |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 9/1/2024, Vol. 42 Issue 25, p3047-3057, 12p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|